Correction: EPS8 Inhibition Increases Cisplatin Sensitivity in Lung Cancer Cells

Podobne zapisy

• EPS8 Inhibition Increases Cisplatin Sensitivity in Lung Cancer Cells
  od: Gorsic, Lidija K., i wsp.
  Wydane: (2013)
• PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells
  od: Cheng, Haiying, i wsp.
  Wydane: (2013)
• Inhibiting the MCM8‐9 complex selectively sensitizes cancer cells to cisplatin and olaparib
  od: Morii, Issay, i wsp.
  Wydane: (2019)
• Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer
  od: Rose, Maimon C., i wsp.
  Wydane: (2014)
• Simultaneous targeting of ATM and Mcl-1 increases cisplatin sensitivity of cisplatin-resistant non-small cell lung cancer
  od: Zhang, Fuquan, i wsp.
  Wydane: (2017)